Effect of Cichorium intybus L. seed extract on renal parameters in experimentally induced early and late diabetes type 2 in rats

References

• Marsenic O. Glucose control by the kidney: An emerging target in diabetes. Am J Kidney Dis. 2009;53:875–883.
   PubMed Web of Science ®Google Scholar
• Rebić D, Hadžović-Džuvo A, Valjevac A. Chronic kidney disease and endothelium. EMJ Nephrol. 2015;3:111–117.
   Google Scholar
• Heydari I, Radi V, Razmjou S, Amiri A. Chronic complications of diabetes mellitus in newly diagnosed patients. Int J Diabetes Mellit. 2010;2:61–63.
   Google Scholar
• Hong D, Zhang Y, Gao B, et al. Metabolic syndrome without diabetes or hypertension still necessitates early screening for chronic kidney disease: information from a Chinese National Cross-Sectional Study. Plos One. 2015;10:e0132220.
   PubMed Web of Science ®Google Scholar
• Ahmad J. Management of diabetic nephropathy: Recent progress and future perspective. Diabetes Metab Syndr. 2015;9:343–358.
   PubMed Web of Science ®Google Scholar
• Imai E, Ito S, Haneda M, et al. Effects of blood pressure on renal and cardiovascular outcomes in Asian patients with type 2 diabetes and overt nephropathy: A post hoc analysis (ORIENT-blood pressure). Nephrol Dial Transpl. 2016;31:447–454.
   PubMed Web of Science ®Google Scholar
• Danda RS, Habiba NM, Rincon-Choles H, et al. Kidney involvement in a nongenetic rat model of type 2 diabetes. Kidney Int. 2005;68:2562–2571.
   PubMed Web of Science ®Google Scholar
• Viberti GC, Hill RD, Jarrett RJ, et al. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet. 1982;1:1430–1432.
   PubMed Web of Science ®Google Scholar
• Dunkler D, Gao P, Lee SF, et al. Risk prediction for early CKD in type 2 diabetes. Clin J Am Soc Nephrol. 2015;10:1371–1379.
   PubMed Web of Science ®Google Scholar
• Foon TS, Yook Chin C, Chinna K. Rate of decline of kidney function in patients with type 2 diabetes mellitus and the associated factors: A10-year retrospective cohort study. Asia Pac J Public Health. 2015;27:NP640–NP649.
   PubMed Web of Science ®Google Scholar
• Hong J, Zhang JP, Xie LT, et al. Significance of normal range urinary albumin to creatinine ratio in Chinese subjects with metabolic syndrome. J Huazhong Univ Sci Technol Med Sci. 2015;35:862–867.
   PubMed Web of Science ®Google Scholar
• Mandal AK, Hiebert L. Diagnosis and management of diabetes and the relationship of dglucose to kidney function. Curr Diabetes Rev. 2015;11:116–121.
   PubMed Web of Science ®Google Scholar
• McMahon GM, Waikar SS. Biomarkers in nephrology: Core Curriculum 2013. Am J Kidney Dis. 2013;62:165–178.
   PubMed Web of Science ®Google Scholar
• Ghamarian A, Abdollahi M, Su X, et al. Effect of chicory seed extract on glucose tolerance test (GTT) and metabolic profile in early and late stage diabetic rats. Daru. 2012;20:56.
   PubMed Web of Science ®Google Scholar
• Ziamajidi N, Khaghani S, Hassanzadeh G, et al. Amelioration by chicory seed extract of diabetes- and oleic acid-induced non-alcoholic fatty liver disease (NAFLD)/non-alcoholic steatohepatitis (NASH) via modulation of PPARalpha and SREBP-1. Food Chem Toxicol. 2013;58:198–209.
   PubMed Web of Science ®Google Scholar
• Rezagholizadeh L, Pourfarjam Y, Nowrouzi A, et al. Effect of Cichorium intybus L. on the expression of hepatic NF-κB and IKKβ and serum TNF-α in STZ- and STZ + niacinamide-induced diabetes in rats. Diabetol Metab Syndr. 2016;8:11.
   PubMed Web of Science ®Google Scholar
• Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254.
   PubMed Web of Science ®Google Scholar
• Han HJ, Lim MJ, Lee YJ, et al. Effects of TCDD and estradiol-17beta on the proliferation and Na+/glucose cotransporter in renal proximal tubule cells. Toxicol in Vitro. 2005;19:21–30.
   PubMed Web of Science ®Google Scholar
• Riphagen IJ, Logtenberg SJJ, Groenier KH, et al. Is the association of serum sodium with mortality in patients with type 2 diabetes explained by copeptin or NT-proBNP? (ZODIAC-46). Atherosclerosis. 2015;242:179–185.
   PubMed Web of Science ®Google Scholar
• Liamis G, Liberopoulos E, Barkas F, Elisaf M. Diabetes mellitus and electrolyte disorders. World J Clin Cases. 2014;2:488–496.
   PubMed Web of Science ®Google Scholar
• Sterns RH, Cox M, Feig PU, Singer I. Internal potassium balance and the control of the plasma potassium concentration. Medicine. 1981;60:339–354.
   PubMed Web of Science ®Google Scholar
• Workeneh B, Bajaj M. The regulation of muscle protein turnover in diabetes. Int J Biochem Cell Biol. 2013;45:2239–2244.
   PubMed Web of Science ®Google Scholar
• Li LX, Wang AP, Zhang R, et al. Decreased urine uric acid excretion is an independent risk factor for chronic kidney disease but not for carotid atherosclerosis in hospital-based patients with type 2 diabetes: A cross-sectional study. Cardiovasc Diabetol. 2015;14:36.
   PubMed Web of Science ®Google Scholar
• Hovind P, Rossing P, Johnson RJ, Parving HH. Serum uric acid as a new player in the development of diabetic nephropathy. J Ren Nutr. 2011;21:124–127.
   PubMed Web of Science ®Google Scholar
• Tseng CH. Correlation of uric acid and urinary albumin excretion rate in patients with type 2 diabetes mellitus in Taiwan. Kidney Int. 2005;68:796–801.
   PubMed Web of Science ®Google Scholar
• Kang DH, Nakagawa T, Feng L, et al. A role for uric acid in the progression of renal disease. Clin J Am Soc Nephrol. 2002;13:2888–2897.
   Web of Science ®Google Scholar
• Donaldson MD, Chambers RE, Woolridge MW, Whicher JT. Stability of alpha 1-microglobulin, beta 2-microglobulin and retinol binding protein in urine. Clin Chim Acta. 1989;179:73–77.
   PubMed Web of Science ®Google Scholar
• Elsherbiny NM, Al-Gayyar MM. The role of IL-18 in type 1 diabetic nephropathy: the problem and future treatment. Cytokine. 2016;81:15–22.
   PubMed Web of Science ®Google Scholar
• Polat SB, Ugurlu N, Aslan N, et al. Evaluation of biochemical and clinical markers of endothelial dysfunction and their correlation with urinary albumin excretion in patients with type 1 diabetes mellitus. Arch Endocrinol Metab. 2016;60:117–124.
   PubMed Web of Science ®Google Scholar
• Gross ML, Ritz E, Schoof A, et al. Comparison of renal morphology in the Streptozotocin and the SHR/N-cp models of diabetes. Lab Invest. 2004;84:452–464.
   PubMed Web of Science ®Google Scholar
• Zhang YW, Wu CY, Cheng JT. Merit of Astragalus polysaccharide in the improvement of early diabetic nephropathy with an effect on mRNA expressions of NF-kappaB and IkappaB in renal cortex of streptozotoxin-induced diabetic rats. J Ethnopharmacol. 2007;114:387–392.
   PubMed Web of Science ®Google Scholar
• Samuel T, Hoy WE, Douglas-Denton R, et al. Applicability of the glomerular size distribution coefficient in assessing human glomerular volume: The Weibel and Gomez method revisited. J Anat. 2007;210:578–582.
   PubMed Web of Science ®Google Scholar
• Alhaider AA, Korashy HM, Sayed-Ahmed MM, et al. Metformin attenuates streptozotocin-induced diabetic nephropathy in rats through modulation of oxidative stress genes expression. Chem Biol Interact. 2011;192:233–242.
   PubMed Web of Science ®Google Scholar
• Kim J, Shon E, Kim CS, Kim JS. Renal podocyte injury in a rat model of type 2 diabetes is prevented by metformin. Exp Diabetes Res. 2012;2012:210821.
   PubMedGoogle Scholar
• Tseng CH. Use of metformin and risk of kidney cancer in patients with type 2 diabetes. Eur J Cancer. 2016;52:19–25.
   PubMed Web of Science ®Google Scholar
• Gallo LA, Wright EM, Vallon V. Probing SGLT2 as a therapeutic target for diabetes: basic physiology and consequences. Diab Vasc Dis Res. 2015;12:78–89.
   PubMed Web of Science ®Google Scholar
• Osorio H, Coronel I, Arellano A, et al. Ursodeoxycholic acid decreases sodium-glucose cotransporter (SGLT2) expression and oxidative stress in the kidney of diabetic rats. Diabetes Res Clin Pract. 2012;97:276–282.
   PubMed Web of Science ®Google Scholar
• Petrovic J, Stanojkovic A, Comic L, Curcic S. Antibacterial activity of Cichorium intybus. Fitoterapia. 2004;75:737–739.
   PubMed Web of Science ®Google Scholar
• Alvarez CA, Neeland IJ, McGuire DK. Sodium-glucose co-transporter inhibition in the treatment of diabetes: Sweetening the pot. Diab Vasc Dis Res. 2015;12:74–77.
   PubMed Web of Science ®Google Scholar
• Lenzen S, Lortz S, Tiedge M. Effect of metformin on SGLT1, GLUT2, and GLUT5 hexose transporter gene expression in small intestine from rats. Biochem Pharmacol. 1996;51:893–896.
   PubMed Web of Science ®Google Scholar